Covered recipient · General Payments record
MARISA CASSARA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2022–2024
$1,158.51
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $472.41 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $179.19 | 4 |
| INTRA-SANA LABORATORIES | $154.91 | 7 |
| Novo Nordisk AS | $92.49 | 4 |
| VIVUS LLC | $45.82 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Intra-Sana Laboratories | $49.91 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138621226 | CMS |
| Intra-Sana Laboratories | $23.21 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138621228 | CMS |
| Intra-Sana Laboratories | $18.83 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138621230 | CMS |
| Intra-Sana Laboratories | $21.13 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138621232 | CMS |
| Intra-Sana Laboratories | $2.70 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138621234 | CMS |
| Intra-Sana Laboratories | $21.13 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138621236 | CMS |
| Intra-Sana Laboratories | $18.00 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138621238 | CMS |
| Lilly USA, LLC | $19.48 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135755617 | CMS |
| Lilly USA, LLC | $21.08 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135813555 | CMS |
| Lilly USA, LLC | $20.87 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135808087 | CMS |
| Lilly USA, LLC | $117.76 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135743520 | CMS |
| Novo Nordisk Inc | $22.72 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100573578 | CMS |
| Novo Nordisk Inc | $22.70 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100292557 | CMS |
| Novo Nordisk Inc | $22.91 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100364459 | CMS |
| Novo Nordisk Inc | $24.16 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100506875 | CMS |
| VIVUS LLC | $21.27 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129419307 | CMS |
| VIVUS LLC | $24.55 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129419309 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.